News for Healthier Living

ESMO: 10-Year Survival Data for Lung Cancer Immunotherapy, New Psma-Targeted Therapy for Recurrent Prostate Cancer, Promising Results in Metastatic Colorectal and Urothelial Cancers

Highlights include a decade of survival data from immunotherapy for advanced lung cancer, a novel PSMA-targeted radioligand therapy offering new hope for men with recurrent prostate cancer, encouraging clinical trial results in colorectal cancer and a potential new therapy for advanced bladder cancer.

October 20, 2025


October 29 2025

October 28 2025

October 27 2025

October 26 2025

October 25 2025

October 24 2025

October 23 2025

October 22 2025

October 21 2025

October 20 2025

October 19 2025

October 18 2025

October 17 2025

October 16 2025